Literature DB >> 26811536

The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Rebekah G Langston1, Iakov N Rudenko1, Mark R Cookson2.   

Abstract

In the period since LRRK2 (leucine-rich repeat kinase 2) was identified as a causal gene for late-onset autosomal dominant parkinsonism, a great deal of work has been aimed at understanding whether the LRRK2 protein might be a druggable target for Parkinson's disease (PD). As part of this effort, animal models have been developed to explore both the normal and the pathophysiological roles of LRRK2. However, LRRK2 is part of a wider family of proteins whose functions in different organisms remain poorly understood. In this review, we compare the information available on biochemical properties of LRRK2 homologues and orthologues from different species from invertebrates (e.g. Caenorhabditis elegans and Drosophila melanogaster) to mammals. We particularly discuss the mammalian LRRK2 homologue, LRRK1, and those species where there is only a single LRRK homologue, discussing examples where each of the LRRK family of proteins has distinct properties as well as those cases where there appear to be functional redundancy. We conclude that uncovering the function of LRRK2 orthologues will help to elucidate the key properties of human LRRK2 as well as to improve understanding of the suitability of different animal models for investigation of LRRK2-related PD.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  GTPase; LRRK2 homologue; animal models; dopaminergic neurons; kinase; neurodegeneration; preclinical research

Mesh:

Substances:

Year:  2016        PMID: 26811536      PMCID: PMC5165698          DOI: 10.1042/BJ20150985

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  141 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.

Authors:  Ravindra Boddu; Travis D Hull; Subhashini Bolisetty; Xianzhen Hu; Mark S Moehle; João Paulo Lima Daher; Ahmed Ibrahim Kamal; Reny Joseph; James F George; Anupam Agarwal; Lisa M Curtis; Andrew B West
Journal:  Hum Mol Genet       Date:  2015-04-22       Impact factor: 6.150

3.  LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism.

Authors:  Amaia M Arranz; Lore Delbroek; Kristof Van Kolen; Marco R Guimarães; Wim Mandemakers; Guy Daneels; Samer Matta; Sara Calafate; Hamdy Shaban; Pieter Baatsen; Pieter-Jan De Bock; Kris Gevaert; Pieter Vanden Berghe; Patrik Verstreken; Bart De Strooper; Diederik Moechars
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

4.  Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S.

Authors:  Xianting Li; Jyoti C Patel; Jing Wang; Marat V Avshalumov; Charles Nicholson; Joseph D Buxbaum; Gregory A Elder; Margaret E Rice; Zhenyu Yue
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

Review 5.  The Roco protein family: a functional perspective.

Authors:  Ignacio Marín; Wouter N van Egmond; Peter J M van Haastert
Journal:  FASEB J       Date:  2008-06-03       Impact factor: 5.191

Review 6.  The GTPase function of LRRK2.

Authors:  Jean-Marc Taymans
Journal:  Biochem Soc Trans       Date:  2012-10       Impact factor: 5.407

7.  Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.

Authors:  Yanping Li; Wencheng Liu; Tinmarla F Oo; Lei Wang; Yi Tang; Vernice Jackson-Lewis; Chun Zhou; Kindiya Geghman; Mikhail Bogdanov; Serge Przedborski; M Flint Beal; Robert E Burke; Chenjian Li
Journal:  Nat Neurosci       Date:  2009-06-07       Impact factor: 24.884

8.  Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

Authors:  Byoung Dae Lee; Joo-Ho Shin; Jackalina VanKampen; Leonard Petrucelli; Andrew B West; Han Seok Ko; Yun-Il Lee; Kathleen A Maguire-Zeiss; William J Bowers; Howard J Federoff; Valina L Dawson; Ted M Dawson
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

9.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.

Authors:  Martin C Herzig; Carine Kolly; Elke Persohn; Diethilde Theil; Tatjana Schweizer; Thomas Hafner; Christine Stemmelen; Thomas J Troxler; Peter Schmid; Simone Danner; Christian R Schnell; Matthias Mueller; Bernd Kinzel; Armelle Grevot; Federico Bolognani; Martina Stirn; Rainer R Kuhn; Klemens Kaupmann; P Herman van der Putten; Giorgio Rovelli; Derya R Shimshek
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 10.  Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Authors:  Iakov N Rudenko; Ruth Chia; Mark R Cookson
Journal:  BMC Med       Date:  2012-02-23       Impact factor: 8.775

View more
  13 in total

Review 1.  In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  Stem Cells Dev       Date:  2018-03-29       Impact factor: 3.272

2.  Structure, function, and leucine-rich repeat kinase 2: On the importance of reproducibility in understanding Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-15       Impact factor: 11.205

3.  Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.

Authors:  Md Shariful Islam; Hendrik Nolte; Wright Jacob; Anna B Ziegler; Stefanie Pütz; Yael Grosjean; Karolina Szczepanowska; Aleksandra Trifunovic; Thomas Braun; Hermann Heumann; Rolf Heumann; Bernhard Hovemann; Darren J Moore; Marcus Krüger
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

4.  Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2.

Authors:  Rebekah G Langston; Iakov N Rudenko; Ravindran Kumaran; David N Hauser; Alice Kaganovich; Luis Bonet Ponce; Adamantios Mamais; Kelechi Ndukwe; Allissa A Dillman; Amr M Al-Saif; Aleksandra Beilina; Mark R Cookson
Journal:  Neurochem Res       Date:  2018-10-05       Impact factor: 3.996

5.  Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo.

Authors:  Elena Kozina; Shankar Sadasivan; Yun Jiao; Yuchen Dou; Zhijun Ma; Haiyan Tan; Kiran Kodali; Timothy Shaw; Junmin Peng; Richard J Smeyne
Journal:  Brain       Date:  2018-06-01       Impact factor: 15.255

6.  LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation.

Authors:  Eun-Jin Bae; Dong-Kyu Kim; Changyoun Kim; Michael Mante; Anthony Adame; Edward Rockenstein; Ayse Ulusoy; Michael Klinkenberg; Ga Ram Jeong; Jae Ryul Bae; Cheolsoon Lee; He-Jin Lee; Byung-Dae Lee; Donato A Di Monte; Eliezer Masliah; Seung-Jae Lee
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

Review 7.  Nutrigenomics as a tool to study the impact of diet on aging and age-related diseases: the Drosophila approach.

Authors:  Zoi Evangelakou; Maria Manola; Sentiljana Gumeni; Ioannis P Trougakos
Journal:  Genes Nutr       Date:  2019-05-02       Impact factor: 5.523

Review 8.  LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease.

Authors:  Eunice Eun Seo Chang; Philip Wing-Lok Ho; Hui-Fang Liu; Shirley Yin-Yu Pang; Chi-Ting Leung; Yasine Malki; Zoe Yuen-Kiu Choi; David Boyer Ramsden; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2022-02-14       Impact factor: 8.014

Review 9.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

Review 10.  VEGF Signaling in Neurological Disorders.

Authors:  Joon W Shim; Joseph R Madsen
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.